Literature for razaxaban (S01.216 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2005
1. Quan,M.L., Lam,P.Y., Han,Q., Pinto,D.J., He,M.Y., Li,R., Ellis,C.D., Clark,C.G., Teleha,C.A., Sun,J.H., Alexander,R.S., Bai,S., Luettgen,J.M., Knabb,R.M., Wong,P.C. and Wexler,R.R.
   Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor
   J Med Chem48, 1729-1744. PubMed  Europe PubMed DOI  I